Abiraterone
The serum concentration of Primaquine can be increased when it is combined with Abiraterone.
Acebutolol
The metabolism of Acebutolol can be decreased when combined with Primaquine.
Acepromazine
The serum concentration of Acepromazine can be increased when it is combined with Primaquine.
Advertisement
Aceprometazine
The serum concentration of Aceprometazine can be increased when it is combined with Primaquine.
Acetyldigitoxin
The serum concentration of Acetyldigitoxin can be increased when it is combined with Primaquine.
Albendazole
The serum concentration of Albendazole can be decreased when it is combined with Primaquine.
Advertisement
Albuterol
Salbutamol may increase the QTc-prolonging activities of Primaquine.
Alfuzosin
Alfuzosin may increase the QTc-prolonging activities of Primaquine.
Alprenolol
The metabolism of Alprenolol can be decreased when combined with Primaquine.
Advertisement
Amantadine
Amantadine may increase the QTc-prolonging activities of Primaquine.
Amiodarone
Primaquine may increase the QTc-prolonging activities of Amiodarone.
Amitriptyline
Amitriptyline may increase the QTc-prolonging activities of Primaquine.
Amoxapine
Amoxapine may increase the QTc-prolonging activities of Primaquine.
Anagrelide
Primaquine may increase the QTc-prolonging activities of Anagrelide.
Apalutamide
The serum concentration of Primaquine can be decreased when it is combined with Apalutamide.
Apomorphine
Apomorphine may increase the QTc-prolonging activities of Primaquine.
Aprepitant
The serum concentration of Primaquine can be increased when it is combined with Aprepitant.
Arformoterol
Arformoterol may increase the QTc-prolonging activities of Primaquine.
Aripiprazole
Aripiprazole may increase the QTc-prolonging activities of Primaquine.
Arsenic Trioxide
Primaquine may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
The risk or severity of QTc prolongation can be increased when Primaquine is combined with Artemether.
Asenapine
Primaquine may increase the QTc-prolonging activities of Asenapine.
Atazanavir
The metabolism of Primaquine can be decreased when combined with Atazanavir.
Atenolol
The metabolism of Atenolol can be decreased when combined with Primaquine.
Atomoxetine
The metabolism of Primaquine can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Primaquine is combined with Atorvastatin.
Azithromycin
Azithromycin may increase the QTc-prolonging activities of Primaquine.
Bedaquiline
Primaquine may increase the QTc-prolonging activities of Bedaquiline.
Benzimidazole
The serum concentration of Benzimidazole can be decreased when it is combined with Primaquine.
Betaxolol
The metabolism of Betaxolol can be decreased when combined with Primaquine.
Bisoprolol
The metabolism of Bisoprolol can be decreased when combined with Primaquine.
Boceprevir
The metabolism of Primaquine can be decreased when combined with Boceprevir.
Bopindolol
The metabolism of Bopindolol can be decreased when combined with Primaquine.
Bortezomib
The metabolism of Primaquine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Primaquine can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Primaquine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Primaquine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Primaquine.
Bupranolol
The metabolism of Bupranolol can be decreased when combined with Primaquine.
Buserelin
Buserelin may increase the QTc-prolonging activities of Primaquine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Primaquine.
Caffeine
The metabolism of Primaquine can be decreased when combined with Caffeine.
Carbamazepine
The metabolism of Primaquine can be increased when combined with Carbamazepine.
Carteolol
The metabolism of Carteolol can be decreased when combined with Primaquine.
Carvedilol
The metabolism of Carvedilol can be decreased when combined with Primaquine.
Celiprolol
The metabolism of Celiprolol can be decreased when combined with Primaquine.
Ceritinib
The serum concentration of Primaquine can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Primaquine.
Chloroquine
Chloroquine may increase the QTc-prolonging activities of Primaquine.
Chloroxylenol
The serum concentration of Chloroxylenol can be decreased when it is combined with Primaquine.
Chlorpromazine
Chlorpromazine may increase the QTc-prolonging activities of Primaquine.
Ciprofloxacin
Ciprofloxacin may increase the QTc-prolonging activities of Primaquine.
Cisapride
Primaquine may increase the QTc-prolonging activities of Cisapride.
Citalopram
Primaquine may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
The metabolism of Primaquine can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Primaquine can be decreased when combined with Clemastine.
Clomipramine
Clomipramine may increase the QTc-prolonging activities of Primaquine.
Clotrimazole
The metabolism of Primaquine can be decreased when combined with Clotrimazole.
Clozapine
Clozapine may increase the QTc-prolonging activities of Primaquine.
Cobicistat
The metabolism of Primaquine can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Primaquine.
Crizotinib
Primaquine may increase the QTc-prolonging activities of Crizotinib.
Cyclosporine
The metabolism of Primaquine can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The serum concentration of Primaquine can be decreased when it is combined with Cyproterone acetate.
Dabrafenib
The serum concentration of Primaquine can be decreased when it is combined with Dabrafenib.
Dapsone
The risk or severity of adverse effects can be increased when Primaquine is combined with Dapsone.
Darunavir
The metabolism of Primaquine can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Primaquine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Primaquine can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Primaquine can be decreased when it is combined with Deferasirox.
Degarelix
Degarelix may increase the QTc-prolonging activities of Primaquine.
Delavirdine
The metabolism of Primaquine can be decreased when combined with Delavirdine.
Desflurane
Desflurane may increase the QTc-prolonging activities of Primaquine.
Desipramine
Desipramine may increase the QTc-prolonging activities of Primaquine.
Deslanoside
The serum concentration of Deslanoside can be increased when it is combined with Primaquine.
Diethylcarbamazine
The serum concentration of Diethylcarbamazine can be decreased when it is combined with Primaquine.
Digitoxin
The serum concentration of Digitoxin can be increased when it is combined with Primaquine.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Primaquine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Primaquine.
Diltiazem
The metabolism of Primaquine can be decreased when combined with Diltiazem.
Diphenhydramine
Diphenhydramine may increase the QTc-prolonging activities of Primaquine.
Disopyramide
Primaquine may increase the QTc-prolonging activities of Disopyramide.
Dofetilide
Primaquine may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Dolasetron may increase the QTc-prolonging activities of Primaquine.
Domperidone
Primaquine may increase the QTc-prolonging activities of Domperidone.
Dothiepin
The metabolism of Primaquine can be decreased when combined with Dosulepin.
Doxepin
Doxepin may increase the QTc-prolonging activities of Primaquine.
Doxycycline
The metabolism of Primaquine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Primaquine can be decreased when combined with Doxycycline.
Dronedarone
Primaquine may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Droperidol may increase the QTc-prolonging activities of Primaquine.
Eliglustat
Primaquine may increase the QTc-prolonging activities of Eliglustat.
Enzalutamide
The serum concentration of Primaquine can be decreased when it is combined with Enzalutamide.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Primaquine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Primaquine.
Eribulin
Eribulin may increase the QTc-prolonging activities of Primaquine.
Erythromycin
Erythromycin may increase the QTc-prolonging activities of Primaquine.
Escitalopram
Primaquine may increase the QTc-prolonging activities of Escitalopram.
Esmolol
The metabolism of Esmolol can be decreased when combined with Primaquine.
Ezogabine
Ezogabine may increase the QTc-prolonging activities of Primaquine.
Famotidine
Famotidine may increase the QTc-prolonging activities of Primaquine.
Felbamate
Felbamate may increase the QTc-prolonging activities of Primaquine.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Primaquine.
Fingolimod
Fingolimod may increase the QTc-prolonging activities of Primaquine.
Flecainide
Primaquine may increase the QTc-prolonging activities of Flecainide.
Flubendazole
The serum concentration of Flubendazole can be decreased when it is combined with Primaquine.
Fluconazole
The metabolism of Primaquine can be decreased when combined with Fluconazole.
Fluoxetine
Primaquine may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Primaquine may increase the QTc-prolonging activities of Flupentixol.
Fluphenazine
The serum concentration of Fluphenazine can be increased when it is combined with Primaquine.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Primaquine.
Fluvoxamine
The metabolism of Primaquine can be decreased when combined with Fluvoxamine.
Formoterol
Formoterol may increase the QTc-prolonging activities of Primaquine.
Fosamprenavir
The metabolism of Primaquine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Primaquine can be increased when it is combined with Fosaprepitant.
Foscarnet
Foscarnet may increase the QTc-prolonging activities of Primaquine.
Fosphenytoin
The metabolism of Primaquine can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Primaquine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Primaquine can be increased when it is combined with Fusidic Acid.
Gadobenate
Gadobenic acid may increase the QTc-prolonging activities of Primaquine.
Galantamine
Galantamine may increase the QTc-prolonging activities of Primaquine.
Gemifloxacin
Primaquine may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Primaquine may increase the QTc-prolonging activities of Gemifloxacin.
Goserelin
Goserelin may increase the QTc-prolonging activities of Primaquine.
Granisetron
Granisetron may increase the QTc-prolonging activities of Primaquine.
Haloperidol
Haloperidol may increase the QTc-prolonging activities of Primaquine.
Hexylresorcinol
The serum concentration of Hexylresorcinol can be decreased when it is combined with Primaquine.
Histrelin
Histrelin may increase the QTc-prolonging activities of Primaquine.
Hydroxyzine
Hydroxyzine may increase the QTc-prolonging activities of Primaquine.
Hypoxis hemerocallidea root extract
The serum concentration of Primaquine can be decreased when it is combined with St. John's Wort.
Ibandronate
Ibandronate may increase the QTc-prolonging activities of Primaquine.
Ibandronic Acid
Ibandronate may increase the QTc-prolonging activities of Primaquine.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Primaquine.
Ibutilide
Primaquine may increase the QTc-prolonging activities of Ibutilide.
Idelalisib
The metabolism of Primaquine can be decreased when combined with Idelalisib.
Iloperidone
Primaquine may increase the QTc-prolonging activities of Iloperidone.
Imatinib
The metabolism of Primaquine can be decreased when combined with Imatinib.
Imipramine
Imipramine may increase the QTc-prolonging activities of Primaquine.
Indacaterol
Indacaterol may increase the QTc-prolonging activities of Primaquine.
Indapamide
Indapamide may increase the QTc-prolonging activities of Primaquine.
Indinavir
The metabolism of Primaquine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Primaquine can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Primaquine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Primaquine can be decreased when combined with Isavuconazonium.
Isoflurane
Isoflurane may increase the QTc-prolonging activities of Primaquine.
Isradipine
The metabolism of Primaquine can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Primaquine can be decreased when combined with Itraconazole.
Ivabradine
Ivabradine may increase the QTc-prolonging activities of Primaquine.
Ivacaftor
The serum concentration of Primaquine can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Primaquine can be decreased when combined with Ketoconazole.
Labetalol
The metabolism of Labetalol can be decreased when combined with Primaquine.
Lapatinib
Lapatinib may increase the QTc-prolonging activities of Primaquine.
Lenvatinib
Primaquine may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Primaquine may increase the QTc-prolonging activities of Lenvatinib.
Leuprolide
Leuprolide may increase the QTc-prolonging activities of Primaquine.
Levamisole
The serum concentration of Levamisole can be decreased when it is combined with Primaquine.
Levobunolol
The metabolism of Levobunolol can be decreased when combined with Primaquine.
Levofloxacin
Primaquine may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Primaquine may increase the QTc-prolonging activities of Levofloxacin.
Lidocaine
The metabolism of Primaquine can be decreased when combined with Lidocaine.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Primaquine.
Lithium
Lithium may increase the QTc-prolonging activities of Primaquine.
Lithium Cation
Lithium may increase the QTc-prolonging activities of Primaquine.
Lopinavir
Primaquine may increase the QTc-prolonging activities of Lopinavir.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Primaquine.
Luliconazole
The serum concentration of Primaquine can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Primaquine can be increased when combined with Lumacaftor.
Lumefantrine
The risk or severity of QTc prolongation can be increased when Primaquine is combined with Lumefantrine.
Maprotiline
Maprotiline may increase the QTc-prolonging activities of Primaquine.
Mebendazole
The serum concentration of Mebendazole can be decreased when it is combined with Primaquine.
Mefloquine
The risk or severity of adverse effects can be increased when Primaquine is combined with Mefloquine.
Mesoridazine
The serum concentration of Mesoridazine can be increased when it is combined with Primaquine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Primaquine.
Methadone
Methadone may increase the QTc-prolonging activities of Primaquine.
Methotrimeprazine
The serum concentration of Methotrimeprazine can be increased when it is combined with Primaquine.
Methylene blue
The serum concentration of Methylene blue can be increased when it is combined with Primaquine.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Primaquine.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Primaquine.
Metipranolol
The metabolism of Metipranolol can be decreased when combined with Primaquine.
Metoclopramide
Metoclopramide may increase the QTc-prolonging activities of Primaquine.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Primaquine.
Metronidazole
Metronidazole may increase the QTc-prolonging activities of Primaquine.
Mexiletine
The metabolism of Primaquine can be decreased when combined with Mexiletine.
Midostaurin
The metabolism of Primaquine can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Primaquine can be increased when it is combined with Mifepristone.
Mirabegron
Mirabegron may increase the QTc-prolonging activities of Primaquine.
Mirtazapine
Mirtazapine may increase the QTc-prolonging activities of Primaquine.
Mitotane
The serum concentration of Primaquine can be decreased when it is combined with Mitotane.
Moexipril
Moexipril may increase the QTc-prolonging activities of Primaquine.
Moricizine
The serum concentration of Moricizine can be increased when it is combined with Primaquine.
Moxidectin
The serum concentration of Moxidectin can be decreased when it is combined with Primaquine.
Moxifloxacin
Moxifloxacin may increase the QTc-prolonging activities of Primaquine.
Nadolol
The metabolism of Nadolol can be decreased when combined with Primaquine.
Nebivolol
The metabolism of Nebivolol can be decreased when combined with Primaquine.
Nefazodone
The metabolism of Primaquine can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Primaquine can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Primaquine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Primaquine can be increased when combined with Nevirapine.
Nicardipine
Nicardipine may increase the QTc-prolonging activities of Primaquine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Primaquine.
Niclosamide
The serum concentration of Niclosamide can be decreased when it is combined with Primaquine.
Nilotinib
Primaquine may increase the QTc-prolonging activities of Nilotinib.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Primaquine.
Norfloxacin
Norfloxacin may increase the QTc-prolonging activities of Primaquine.
Nortriptyline
Nortriptyline may increase the QTc-prolonging activities of Primaquine.
Octreotide
Octreotide may increase the QTc-prolonging activities of Primaquine.
Ofloxacin
Primaquine may increase the QTc-prolonging activities of Ofloxacin.
Olanzapine
Olanzapine may increase the QTc-prolonging activities of Primaquine.
Olaparib
The metabolism of Primaquine can be decreased when combined with Olaparib.
Olodaterol
Olodaterol may increase the QTc-prolonging activities of Primaquine.
Ondansetron
Ondansetron may increase the QTc-prolonging activities of Primaquine.
Osimertinib
The serum concentration of Primaquine can be increased when it is combined with Osimertinib.
Ouabain
The serum concentration of Ouabain can be increased when it is combined with Primaquine.
Ovine Digoxin Immune Fab
The serum concentration of Digoxin Immune Fab (Ovine) can be increased when it is combined with Primaquine.
Oxamniquine
The serum concentration of Oxamniquine can be decreased when it is combined with Primaquine.
Oxfendazole
The serum concentration of Oxfendazole can be decreased when it is combined with Primaquine.
Oxibendazole
The serum concentration of Oxibendazole can be decreased when it is combined with Primaquine.
Oxprenolol
The metabolism of Oxprenolol can be decreased when combined with Primaquine.
Oxytocin
Oxytocin may increase the QTc-prolonging activities of Primaquine.
Palbociclib
The serum concentration of Primaquine can be increased when it is combined with Palbociclib.
Paliperidone
Primaquine may increase the QTc-prolonging activities of Paliperidone.
Panobinostat
Primaquine may increase the QTc-prolonging activities of Panobinostat.
Paroxetine
Paroxetine may increase the QTc-prolonging activities of Primaquine.
Pasireotide
Pasireotide may increase the QTc-prolonging activities of Primaquine.
Pazopanib
Primaquine may increase the QTc-prolonging activities of Pazopanib.
Peginterferon Alfa-2b
The serum concentration of Primaquine can be increased when it is combined with Peginterferon alfa-2b.
Penbutolol
The metabolism of Penbutolol can be decreased when combined with Primaquine.
Pentamidine
Pentamidine may increase the QTc-prolonging activities of Primaquine.
Pentobarbital
The metabolism of Primaquine can be increased when combined with Pentobarbital.
Perazine
The serum concentration of Perazine can be increased when it is combined with Primaquine.
Perflutren
Perflutren may increase the QTc-prolonging activities of Primaquine.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Primaquine.
Periciazine
The serum concentration of Propericiazine can be increased when it is combined with Primaquine.
Perphenazine
The serum concentration of Perphenazine can be increased when it is combined with Primaquine.
Phenobarbital
The metabolism of Primaquine can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Primaquine can be increased when combined with Phenytoin.
Pimozide
Primaquine may increase the QTc-prolonging activities of Pimozide.
Pindolol
The metabolism of Pindolol can be decreased when combined with Primaquine.
Piperazine
The serum concentration of Piperazine can be decreased when it is combined with Primaquine.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Primaquine.
Posaconazole
The metabolism of Primaquine can be decreased when combined with Posaconazole.
Practolol
The metabolism of Practolol can be decreased when combined with Primaquine.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Primaquine.
Praziquantel
The serum concentration of Praziquantel can be decreased when it is combined with Primaquine.
Prilocaine
The risk or severity of adverse effects can be increased when Primaquine is combined with Prilocaine.
Primidone
The metabolism of Primaquine can be increased when combined with Primidone.
Procainamide
Primaquine may increase the QTc-prolonging activities of Procainamide.
Prochlorperazine
The serum concentration of Prochlorperazine can be increased when it is combined with Primaquine.
Promazine
Promazine may increase the QTc-prolonging activities of Primaquine.
Promethazine
The serum concentration of Promethazine can be increased when it is combined with Primaquine.
Propafenone
Primaquine may increase the QTc-prolonging activities of Propafenone.
Propofol
Propofol may increase the QTc-prolonging activities of Primaquine.
Propranolol
The metabolism of Propranolol can be decreased when combined with Primaquine.
Proscillaridin
The serum concentration of Proscillaridin can be increased when it is combined with Primaquine.
Protriptyline
Protriptyline may increase the QTc-prolonging activities of Primaquine.
Pyrantel
The serum concentration of Pyrantel can be decreased when it is combined with Primaquine.
Pyrvinium
The serum concentration of Pyrvinium can be decreased when it is combined with Primaquine.
Quetiapine
Primaquine may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Primaquine may increase the QTc-prolonging activities of Quetiapine.
Quinacrine
The serum concentration of Quinacrine can be decreased when it is combined with Primaquine.
Quinidine
Primaquine may increase the QTc-prolonging activities of Quinidine.
Quinine
Primaquine may increase the QTc-prolonging activities of Quinine.
Ranolazine
The metabolism of Primaquine can be decreased when combined with Ranolazine.
Rifabutin
The metabolism of Primaquine can be increased when combined with Rifabutin.
Rifampin
The metabolism of Primaquine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Primaquine can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Primaquine.
Risperidone
Risperidone may increase the QTc-prolonging activities of Primaquine.
Ritonavir
Ritonavir may increase the QTc-prolonging activities of Primaquine.
Ropinirole
The metabolism of Primaquine can be decreased when combined with Ropinirole.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Primaquine.
Rucaparib
The metabolism of Primaquine can be decreased when combined with Rucaparib.
Salmeterol
Salmeterol may increase the QTc-prolonging activities of Primaquine.
Saquinavir
The metabolism of Primaquine can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Primaquine can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Primaquine can be decreased when used in combination with Sarilumab.
Sertraline
Sertraline may increase the QTc-prolonging activities of Primaquine.
Sevoflurane
Sevoflurane may increase the QTc-prolonging activities of Primaquine.
Sildenafil
The metabolism of Primaquine can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Primaquine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Primaquine can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Primaquine.
Sodium Stibogluconate
The serum concentration of Sodium stibogluconate can be decreased when it is combined with Primaquine.
Solifenacin
Solifenacin may increase the QTc-prolonging activities of Primaquine.
Sorafenib
Sorafenib may increase the QTc-prolonging activities of Primaquine.
Sotalol
Primaquine may increase the QTc-prolonging activities of Sotalol.
ST. JOHN'S WORT EXTRACT
The serum concentration of Primaquine can be decreased when it is combined with St. John's Wort.
Sulfamethoxazole
Sulfamethoxazole may increase the QTc-prolonging activities of Primaquine.
Sulfisoxazole
Sulfisoxazole may increase the QTc-prolonging activities of Primaquine.
Sunitinib
Sunitinib may increase the QTc-prolonging activities of Primaquine.
Suramin
The serum concentration of Suramin can be decreased when it is combined with Primaquine.
Talinolol
The metabolism of Talinolol can be decreased when combined with Primaquine.
Tamoxifen
Tamoxifen may increase the QTc-prolonging activities of Primaquine.
Telaprevir
The metabolism of Primaquine can be decreased when combined with Telaprevir.
Telavancin
Primaquine may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The metabolism of Primaquine can be decreased when combined with Telithromycin.
Tenofovir Disoproxil
The metabolism of Primaquine can be decreased when combined with Tenofovir disoproxil.
Terbutaline
Terbutaline may increase the QTc-prolonging activities of Primaquine.
Terbutaline Sulfate
Terbutaline may increase the QTc-prolonging activities of Primaquine.
Teriflunomide
The serum concentration of Primaquine can be decreased when it is combined with Teriflunomide.
Tetrabenazine
Primaquine may increase the QTc-prolonging activities of Tetrabenazine.
Theophylline
The metabolism of Primaquine can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Primaquine can be decreased when combined with Theophylline.
Thiabendazole
The serum concentration of Thiabendazole can be decreased when it is combined with Primaquine.
Thiethylperazine
The serum concentration of Thiethylperazine can be increased when it is combined with Primaquine.
Thioproperazine
The serum concentration of Thioproperazine can be increased when it is combined with Primaquine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Primaquine.
Thiothixene
Thiothixene may increase the QTc-prolonging activities of Primaquine.
Ticlopidine
The metabolism of Primaquine can be decreased when combined with Ticlopidine.
Timolol
The metabolism of Timolol can be decreased when combined with Primaquine.
Timolol Anhydrous
The metabolism of Timolol can be decreased when combined with Primaquine.
Tizanidine
Tizanidine may increase the QTc-prolonging activities of Primaquine.
Tocilizumab
The serum concentration of Primaquine can be decreased when it is combined with Tocilizumab.
Tolterodine
Tolterodine may increase the QTc-prolonging activities of Primaquine.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Primaquine.
Toremifene
Primaquine may increase the QTc-prolonging activities of Toremifene.
Trazodone
Trazodone may increase the QTc-prolonging activities of Primaquine.
Treprostinil
Treprostinil may increase the QTc-prolonging activities of Primaquine.
Trifluoperazine
The serum concentration of Trifluoperazine can be increased when it is combined with Primaquine.
Triflupromazine
The serum concentration of Triflupromazine can be increased when it is combined with Primaquine.
Trimeprazine
The serum concentration of Alimemazine can be increased when it is combined with Primaquine.
Trimethoprim
Trimethoprim may increase the QTc-prolonging activities of Primaquine.
Trimipramine
Trimipramine may increase the QTc-prolonging activities of Primaquine.
Triptorelin
Triptorelin may increase the QTc-prolonging activities of Primaquine.
Vandetanib
Primaquine may increase the QTc-prolonging activities of Vandetanib.
Vardenafil
Vardenafil may increase the QTc-prolonging activities of Primaquine.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Primaquine.
Venlafaxine
The metabolism of Primaquine can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Primaquine can be decreased when combined with Verapamil.
Vilanterol
Vilanterol may increase the QTc-prolonging activities of Primaquine.
Voriconazole
The metabolism of Primaquine can be decreased when combined with Voriconazole.
Vorinostat
Vorinostat may increase the QTc-prolonging activities of Primaquine.
Ziprasidone
Primaquine may increase the QTc-prolonging activities of Ziprasidone.
Zuclopenthixol
Primaquine may increase the QTc-prolonging activities of Zuclopenthixol.
